Mei 2012
30
Kuriyama A, Jackson JL, Doi A, and Kamiya T. 2011. Metronidazole-induced central nervous system
toxicity: a systematic review. Clin Neuropharmacol 34:241-247.
Langendonk JG, Roos JC, Angus L, Williams M, Karstens FP, De Klerk JB, Maritz C, Ben-Omran T,
Williamson C, Lachmann RH, and Murphy E. 2011. A series of pregnancies in women with inherited
metabolic disease. J Inherit Metab Dis.
Leonard JV. 1995. The management and outcome of propionic and methylmalonic acidaemia. J
Inherit Metab Dis 18:430-434.
Matern D, Seydewitz HH, Lehnert W, Niederhoff H, Leititis JU, and Brandis M. 1996. Primary
treatment of propionic acidemia complicated by acute thiamine deficiency. J Pediatr 129:758-760.
North KN, Korson MS, Gopal YR, Rohr FJ, Brazelton TB, Waisbren SE, and Warman ML. 1995.
Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for
management. J Pediatr 126:916-922.
Pena L, Franks J, Chapman KA, Gropman A, Ah MN, Chakrapani A, Island E, MacLeod E, Matern D,
Smith B, Stagni K, Sutton VR, Ueda K, Urv T, Venditti C, Enns GM, and Summar ML. 2012a. Natural
history of propionic acidemia. Mol Genet Metab 105:5-9.
Pena L, Franks J, Chapman KA, Gropman A, Ah MN, Chakrapani A, Island E, MacLeod E, Matern D,
Smith B, Stagni K, Sutton VR, Ueda K, Urv T, Venditti C, Enns GM, and Summar ML. 2012b. Natural
history of propionic acidemia. Mol Genet Metab 105:5-9.
Prasad C, Nurko S, Borovoy J, and Korson MS. 2004. The importance of gut motility in the
metabolic control of propionic acidemia. J Pediatr 144:532-535.
Romano S, Valayannopoulos V, Touati G, Jais JP, Rabier D, de KY, Bonnet D, and de LP. 2010.
Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 156:128-
134.
Saudubray J, van den Berghe G, and Walter JH. 2011. Inborn Metabolic Diseases. Wurzburg,
Gemany: Springer.
Schreiber J, Chapman KA, Summar ML, Ah MN, Sutton VR, MacLeod E, Stagni K, Ueda K, Franks J,
Island E, Matern D, Pena L, Smith B, Urv T, Venditti C, Chakarapani A, and Gropman AL. 2012.
Neurologic considerations in propionic acidemia. Mol Genet Metab 105:10-15.
Sutton VR, Chapman KA, Gropman AL, MacLeod E, Stagni K, Summar ML, Ueda K, Ah MN, Franks J,
Island E, Matern D, Pena L, Smith B, Urv T, Venditti C, and Chakarapani A. 2012. Chronic
management and health supervision of individuals with propionic acidemia. Mol Genet Metab
105:26-33.
Thompson GN, Chalmers RA, Walter JH, Bresson JL, Lyonnet SL, Reed PJ, Saudubray JM, Leonard JV,
and Halliday D. 1990. The use of metronidazole in management of methylmalonic and propionic
acidaemias. Eur J Pediatr 149:792-796.
Touati G, Valayannopoulos V, Mention K, de LP, Jouvet P, Depondt E, Assoun M, Souberbielle JC,
Rabier D, Ogier de BH, and Saudubray JM. 2006. Methylmalonic and propionic acidurias:
management without or with a few supplements of specific amino acid mixture. J Inherit Metab
Dis 29:288-298.